CMP Development
Contract manufacturerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
- Group recordsLabelled by a language model (which subsidiaries belong to the group) from the firm's FDA names. It is not an FDA field.: 12, 2 entities
- Drug applications: 8
- Complete response letters: 4
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, CMP Development and its 1 subsidiaries
Latest Records
Newest first across sources; each opens the record| Date | Record | Source |
|---|---|---|
| Apr 28, 2022 | Complete response letter, NDA 214952Approved | Complete response letters |
| Apr 22, 2021 | Complete response letter, NDA 214439Approved | Complete response letters |
| Feb 23, 2021 | Complete response letter, NDA 214522Approved | Complete response letters |
| Oct 16, 2020 | Complete response letter, NDA 213260Approved | Complete response letters |
Subsidiaries and Divisions
1 firms in the CMP Development group, most records first- CMP Development LLC4 records
Names and Identifiers
- Appears as
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built